EBS:NYSE
Emergent Biosolutions Inc
7,03 US$
arrow_upward
+1,74%(+0,12) 1K
14-okt, 13:00:42 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEBS tikeri uchun statistika yaratilmoqda...
Ochish
6,87 US$
Yuqori
7,03 US$
Past
6,81 US$
Bozor kapitali
360,45 mln
Oʻrtacha hajm
1,14 mln
Hajmi
268,23 ming
52 haftalik eng yuqori
14,06 US$
52 haftalik eng past
4,36 US$
Aksiya boʻyicha daromad
-3,51 US$
Beta
2,28
Muomaladagi aksiyalar
51,27 mln
Xodimlar soni
900
Ochish
6,87 US$
Yuqori
7,03 US$
Past
6,81 US$
Bozor kapitali
360,45 mln
Oʻrtacha hajm
1,14 mln
Hajmi
268,23 ming
52 haftalik eng yuqori
14,06 US$
52 haftalik eng past
4,36 US$
Aksiya boʻyicha daromad
-3,51 US$
Beta
2,28
Muomaladagi aksiyalar
51,27 mln
Xodimlar soni
900
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Simply Wall Street
·
53 daqiqa oldin
Palo Alto Networks (PANW) Becomes Founding Partner In Critical Infrastructure Defense Program
巴士的報
·
25 daqiqa oldin
Oracle NetSuite Announces Launch of AI-first QuickStart: NYSE Content Update
24/7 Wall St.
·
29 daqiqa oldin
Michael Burry Says Stocks Could Peak Within 9 Months — and He’s Betting Against the Nasdaq and Chip Stocks
Profil
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
Emergent Biosolutions Inc haqida
CEORobert G. Kramer Sr. | Joseph C. Papa
Xodimlar soni900
Asos solingan5-sen, 1998
Bosh ofislarRockville, Maryland, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytemergentbiosolutions.com